All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Syndicated LoansInvestment Grade Loans

Shire snaffles Dyax for $5.9bn plus kicker for HAE drug

Pharmaceutical 230x150

Shire, the UK pharmaceutical company, has agreed to acquire US company Dyax for $5.9bn in cash. Deutsche Bank and Morgan Stanley are arranging the financing.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree